Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients

Thymus

Volumn 24, Issue 3, 1997, Pages 147-156

  Zerhouni, Bouchra ^a,b   Sanhadji, Kamel ^a,b   Kehrli, Laurence ^a,b   Livrozet, Jean Michel ^a,b   Touraine, Jean Louis ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

AIDS patients; HIV seropositive subjects; interleukins; lymphokine activated killer cell activity; natural killer cell activity

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CASE-CONTROL STUDIES; CYTOTOXICITY, IMMUNOLOGIC; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; TUMOR CELLS, CULTURED;

EID: 0030928511     PISSN: 01656090     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016924923048     Document Type: Article

References (33)

1. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990; 11: 176-180.
2. Brenner BG, Dascal A, Margolese RG, Wainberg MA. Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases, J Leukoc Biol 1989; 46: 75-83.
3. Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B. Mechanism of detective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, II: Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. J Immunol 1987; 139: 55-60.
4. Gryllis C, Wainberg MA, Gornitsky M, Brenner BG. Diminution of inducible lymphokine-activated killer cell activity in individuals with AIDS-related disorders. AIDS 1990; 4: 1205-1212.
5. Brenner BG, Gryllis C, Gornitsky M, Wainberg MA. Changes in natural immunity during the course of HIV-1 infection. Clin Exp Immunol 1993; 93: 142-148.
6. Reynolds CW, Sharrow SO, Ortaldo JR, Herberman RB. Natural killer activity in the rat, II: Analysis of surface antigens on LGL by flow cytometry. J Immunol 1981; 127: 2204-2208.
7. Herberman RB, Ortaldo JR. Natural killer cells: their role in defense against disease. Science 1981; 214: 24-30.
8. Sirianni MC, Soddus S, Malorni W, Arancia G, Aiuti F. Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol 1988; 140: 2565-2568.
9. Bonavida B, Katz J, Gottlieb M. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, I: Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL-2. J Immunol 1986; 137: 1157-1163.
10. Poli G, Introna M, Zanaboni F, Peri G, Carbonari M, Aiuti F. Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol 1985; 62: 128-135.
11. MosmannTR, CofmanRL. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7: 145-173.
12. Trinchieri G, Mastsumoto-Kobayshi M, Clark SC, Sheehra J, London L, Perussia B. Response of resting human peripheral blood natural killer cells to interleukin-2. J Exp Medl984; 160: 1147-1169.
13. Ostensen ME, Thiele DL, Lipsky PE. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells. J Immunol 1987; 138:4185-4191.
14. Trinchieri G, Santoli D, Dee R, Knowles BB. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J Exp Med 1978; 147: 1299-1313.
15. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Löwe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herbermann SH, Clark SC, Azzoni L, Chan SH, Trinchieri G, Perussia B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146: 3074-3081.
16. Bellone G, Amezaga MA, Trinchieri G, Rodeck U. Regulation of NK cell functions by TGF-β1. J Immunol 1995; 55: 1066-1073.
17. Taub DD, Sayers TJ, Carter CR D, Ortaldo JR. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995; 155: 3877-3888.
18. Gryllis C, Wainberg MA, Bentwich Z, Gornitsky M, Brenner BG. Increased LAK activity against HIV-infected cell lines in H1V-1+ individuals. Clin Exp Immunol 1992; 89: 356-361.
19. Rook AH, Masur H, Lane HC, Frederick W, KasaharaT, Macher AM, Djeu J Y, Manischewitz JF, Jackson L, Fauci AS, Quinnan GV. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immunodeficiency syndrome. J Clin Invest 1983; 72: 398-403.
20. Centers for Disease Control. Revision of CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36 (suppl): 1S-14S.
21. Pedersen BK, Kharazmi A. Inhibition of human natural killer cell activity by pseudomonas aeruginosa alkaline protease and elastase. Infect Immun 1987; 55: 986-989.
22. Hale PM, Cease KB, Houghten RA, Ouyang C, Putney S, Javaherian K, Margalit H, Cornette JL, Spouge JL, Delisi C, Berzofsky JA. T cell multideterminant regions in the human immunodeficiency virus envelope: Toward overcoming the problem of major histocompatibility complex restriction. Int Immunol 1989; 1: 409-415.
23. Sirianni MC, Mezzaroma I, Aiuti F, Moretta A. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD 16 monoclonal antibody. Eur J Immunol 1994; 24: 1874-1878.
24. Sirianni MC, Tagliaferri F, Aiuti F. Pathogenesis of the natural killer cell deficiency in AIDS. Immunol Today 1990; 11: 81-82.
25. Fontana L, Sirianni MC, De Sanctis G, Carbonari M, Ensoli B, Aiuti F. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphadenopathy syndrome positive for antibody to HTLV III. Immunobiology 1986; 117: 425-435.
26. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Lianes C, Kobayashi M, Perussia B, Young D, Nickbarg E, Wolf SF, Trinchieri G. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 1992; 175: 789-796.
27. Sirianni MC, Ansotegui IJ, Aiuti F, Wigzell H. Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients. Scand J Immunol 1994; 40: 83-86.
28. Romagnani S. Induction of Thl and Th2 responses: A key role for the "natural" immune response? Immunol Today 1992; 13: 379-381.
29. Germann T, Gately MK, Schoenhaut DS, Lahoff M, Mattner F, Fischer S, Jin SC, Schmitt E, Rüde E. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type I (Thl) but not on Th2 cells. Eur J Immunol 1993; 23: 1762-1770.
30. Quit H, Bhandoola A, Trinchieri G, Haluskey J, Peritt D. Induction of IL-12 responsiveness is impaired in anergic T lymphocytes. J Exp Med 1994; 179: 1065-1070.
31. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93: 768-775.
32. Emilie D, Fior R, Crevon MC, Maillot MC, Boue F, Galanaud P. Cytokine from lymphoid organs of HIV-infected patients: Production and role in the immune disequilibrium of the disease. Res Immunol 1994; 145: 595-600.
33. Prof. Jean-Louis Touraine and Ms Bouchra Zerhouni, INSERM U80, Pavillon P, Hôpital Edouard Herriot, F-69437 Lyon-3, France